Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (201-210 of 484) with videos related to

Pageof 49
Sort By:
American Journal of Epidemiology|July 5, 2012
Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialJeannette M Schenk, Gregory S Calip, Catherine M Tangen, et al.
Acta Ophthalmologica|July 24, 2020
Age-related macular degeneration in a randomized trial of selenium and vitamin E in men: the Select Eye Endpoints (SEE) study (SWOG S0000B)William G Christen, Amy K Darke, John M Gaziano, et al.
The Journal of Urology|June 14, 2008
[-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation studyLori J Sokoll, Yinghui Wang, Ziding Feng, et al.
The Journal of Urology|June 14, 2008
The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsyIan M Thompson, Catherine M Tangen, Donna P Ankerst, et al.
Clinical Prostate Cancer|March 26, 2004
Prostate cancer prevention: what do we know now and when will we know more?Ian M Thompson, Joseph Basler, Deborah Hensley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African AmericansStacie J Shook, Joke Beuten, Kathleen C Torkko, et al.
The Journal of Urology|March 28, 2022
Absolute Prostate Specific Antigen after 6 Months of Androgen Deprivation Therapy Is a Predictor of Overall and Cancer-Specific Mortality in Men with Hormone-Sensitive Prostate CancerFurkan Dursun, Chen-Pin Wang, Daniel MacCarthy, et al.
The Journal of Urology|April 18, 2007
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detectionIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
The Journal of Urology|November 16, 2010
Prospective evaluation of operating characteristics of prostate cancer detection biomarkersYuanyuan Liang, Donna P Ankerst, Norma S Ketchum, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 21, 2010
Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of menJoke Beuten, Jonathan A L Gelfond, Jennifer L Franke, et al.
Pageof 49

Showing results (201-210 of 484) with videos related to

Sort By:
Pageof 49
American Journal of Epidemiology|July 5, 2012
Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialJeannette M Schenk, Gregory S Calip, Catherine M Tangen, et al.
Acta Ophthalmologica|July 24, 2020
Age-related macular degeneration in a randomized trial of selenium and vitamin E in men: the Select Eye Endpoints (SEE) study (SWOG S0000B)William G Christen, Amy K Darke, John M Gaziano, et al.
The Journal of Urology|June 14, 2008
[-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation studyLori J Sokoll, Yinghui Wang, Ziding Feng, et al.
The Journal of Urology|June 14, 2008
The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsyIan M Thompson, Catherine M Tangen, Donna P Ankerst, et al.
Clinical Prostate Cancer|March 26, 2004
Prostate cancer prevention: what do we know now and when will we know more?Ian M Thompson, Joseph Basler, Deborah Hensley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African AmericansStacie J Shook, Joke Beuten, Kathleen C Torkko, et al.
The Journal of Urology|March 28, 2022
Absolute Prostate Specific Antigen after 6 Months of Androgen Deprivation Therapy Is a Predictor of Overall and Cancer-Specific Mortality in Men with Hormone-Sensitive Prostate CancerFurkan Dursun, Chen-Pin Wang, Daniel MacCarthy, et al.
The Journal of Urology|April 18, 2007
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detectionIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
The Journal of Urology|November 16, 2010
Prospective evaluation of operating characteristics of prostate cancer detection biomarkersYuanyuan Liang, Donna P Ankerst, Norma S Ketchum, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 21, 2010
Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of menJoke Beuten, Jonathan A L Gelfond, Jennifer L Franke, et al.
Pageof 49